Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

What doctors want patients to know about injectable peptides

AMA News Wire What doctors want patients to know about injectable peptides Apr 29, 2026 Interest in injectable peptides is rising as more people see them promoted online through health and wellness influencers for weight loss, muscle growth, recovery and anti-

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

AMA News Wire

What doctors want patients to know about injectable peptides

Apr 29, 2026

Interest in injectable peptides is rising as more people see them promoted online through health and wellness influencers for weight loss, muscle growth, recovery and anti-aging. But behind the buzz is a more important question: Are these products safe, effective and backed by evidence? 

Physicians say patients should look past social media claims and marketing promises and start with a conversation with a doctor because some injectable peptides are not regulated and may carry real health risks.

The AMA’s What Doctors Want Patients to Know™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines.

For this installment, Anthony C. Tam, MD, a family and sports medicine physician with Henry Ford Health, took time to discuss what patients should know about injectable peptides. He is also a team physician for USA Wrestling, USA Cycling and USA Volleyball, and head physician for Michigan Special Olympics.

Henry Ford Health is part of the AMA Health System Member Program, which provides enterprise solutions to equip leadership, physicians and care teams with resources to help drive the future of medicine.

Injectable peptides have been around for a while 

“Social media has really focused on this recently, but we've had injectable peptides for a while. One of the most common and heavily used is actually insulin,” said Dr. Tam. "We use insulin injections to help people with diabetes control their blood sugar."

"In the last couple of years, the more notable peptide injections that we have been prescribing are GLP-1 medications, which are better known by brand names like Ozempic or Wegovy," he said. These medications help treat diabetes by controlling “sugars but also serves … to help with weight loss as well" by slowing digestion and making patients feel fuller.

Peptides are now being marketed for wellness

More recently, Dr. Tam noted there has been an influx of people "looking for that edge to improve their health and well-being."

"We're now seeing a wave of other peptide injections that are being marketed by wellness centers and social media influencers," he said. "Unfortunately, many of these products have not been thoroughly tested or reviewed by the Food and Drug Administration, so we don't have data from trials. A lot of these newer peptide injections are promoting anti-aging and improved healing and recovery."

People are using injectable peptides for various reasons

"With these newer injections, the claim that's been studied the most relates to recovery. There was one human trial study involving about 10 to 12 people for knee pain recovery," Dr. Tam said. "The details were limited, but the results suggested there may be some promise in improving overall pain scores."

These newer peptides have some studies, but most are in animal models, not humans, to determine how it would act in the human body. 

“When looking at animal trials and other studies, the results were more promising for overall recovery and anti-aging effects, but there's nothing substantial to show these results would translate to humans," he explained. "And there's minimal evidence on the side effects or consequences of long-term or frequent dosing."

"It's great to see that we're on this route of health, wellness and recovery, but we need more evidence and research before we can make a true recommendation," he said.

There's a big trend in the younger population

When it comes to who is using newer injectable peptides, "it's a lot of different people," said Dr. Tam, noting a growing trend among younger generations, including high school and college-age students involved in "looksmaxxing," which is an online community that primarily targets young men who want to improve their appearance.

"There are also weekend warriors and normal, middle-aged people who are looking for an extra edge to try to improve their health," he said. "Elite athletes also bring up peptide injections, but at that level of competition, we conduct drug testing, and these types of substances aren't allowed."

While interest in new peptide injections continues to grow, Dr. Tam emphasized that "unfortunately, there just isn't enough valuable, statistically significant evidence that points us to be able to recommend them safely."

Newer injectable peptides are not FDA approved

"Insulin and GLP-1s are designed for specific disease, so we know who's a good candidate for them," Dr. Tam said. "With these newer peptides, we don't have the same level of evidence yet. We're not sure about dosing and frequency. What we do know mostly comes from anecdotal reports of side effects."

He added that when research is not standardized, regulated or reviewed by the FDA, there's no guarantee they're being manufactured safely or that the ingredients are what is advertised. On the other hand, he noted, "insulin and GLP-1s are very well studied."

"The interesting thing about GLP-1s is that even with all the research we already have, we're continuing to find even more benefits" and risks related to GLP-1s, Dr. Tam said, "which may be why there's so much interest in these newer peptides. They hint at promising possibilities."

There are not clear guidelines for all peptides

With newer peptide injections, it can be difficult to know who is or isn't a good candidate, while with GLP‑1 medications like semaglutide or Ozempic and Wegovy, doctors have well-established guidelines, said Dr. Tam.

Certain patients—such as those with specific types of endocrine cancers—should avoid GLP‑1s, he explained, and there are clear guidelines for who may benefit most, including people with diabetes, obesity or other chronic conditions that contribute to long-term weight gain.

"It's always best to consult with a physician who can give you the best information and help you make the wisest decision," Dr. Tam advised. "We want to find ways to improve your health in the safest ways possible."

For some peptides, side effects are unknown

With insulin, one of the main side effects is low blood sugar while with GLP‑1s, there's a risk of gastrointestinal issues.

"Sometimes people feel nauseous or experience an upset stomach, diarrhea or constipation," Dr. Tam explained. "There's also a risk of possible pancreatitis with the injections. That's why it's really important to talk with your physician and understand the possible side effects."

He added that newer peptide injections also have side effects that we are still learning about.

"From the research we do have, because they're injections, you can see skin irritation at the injection site," Dr. Tam said. "Fatigue, headaches and GI issues have also been reported. Those seem to be the more common side effects so far, but there's still a lot we don't know" about potential risk to patients.

Newer injectable peptides sold through the "grey market"

FDA approval for peptides, such as insulin and GLP‑1s, ensures oversight of how these medications are manufactured and distributed. But newer peptides that are not FDA‑approved carry additional risks related to possible contamination, safety, sourcing and dosing, according to Dr. Tam, particularly in the grey market where products are manufactured without FDA oversight.

He noted that some of these newer injectable peptides are being sold at wellness spas, online sites and through the grey market for unapproved GLP‑1s, which raises additional safety concerns.

"It's important to know exactly where your peptides come from and how they're manufactured," Dr. Tam said. "Talking it through with your physician can help you make a safer, more informed decision."

It’s important to consult your doctor first

With all substances, “if you don't have all the information about what could or couldn't happen when you take a medication, you might be caught off guard by a reaction or side effects," Dr. Tam said. "You may not know whether something is totally unexpected or actually something we'd anticipate based on the treatment."

"It is similar to blood pressure or diabetes medicines,” he said. “You should always review the possible side effects because if something unusual happens, you know whether that was expected or you need emergency care."

"With the established medications, we have plenty of resources that guide us on proper dosing and how to adjust things if you're having side effects or other issues,” said Dr. Tam. “We don't know much about the newer ones yet." 

That's why it's vital to talk with your physician, he said, adding "more communication is always better."

"All questions are good questions, and I'll always provide the best information and answers I can," Dr. Tam said.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01A peptide identified in a fungus found in northern European pine forests possesses as much power as penicillin as well as vancomycin, according to an international team of researchers.

Reporting in the October 13 issue of Nature, a team from Denmark-based biotech company Novozymes, and researchers from Georgetown University Medical Center and the David Geffen School of Medicine at UCLA, say they have isolated "plectasin," the first defensin ever found in fungi. The research was performed at Novozymes laboratories in Denmark. Defensins are peptides, miniature protein molecules that are produced by a wide range of animals to protect themselves against infection. Humans have defensins in their white blood cells and in their skin, for example, but it is believed that this new fungal defensin, plectasin, is more potent and targets certain bacteria more specifically. Indeed, when plectasin was tested in the laboratory and in animals, it proved to be highly effective against the bacteria Streptococcus pneumoniae, and Streptococcus pyogenes, including strains that are now resistant to conventional antibiotics. These bacteria are responsible for such diseases as meningitis, community-acquired pneumonia, strep throat, life-threatening sepsis, and flesh destroying skin infections. The discovery of plectasin has implications for the development of defensins as a treatment against many common, and deadly, infections, and may initiate a new era of antibiotic discovery and development, said study co-author Michael Zasloff, M.D., Ph.D., Professor in the Departments of Surgery and Pediatrics at Georgetown University Medical Center. Zasloff says that the field of antibiotic development has not changed much since 1929 when Alexander Fleming realized that the fungal "bread mold" Penicillium, which had landed by chance in a Petri dish produced a substance that eliminated colonies of staphylococcal bacteria. "Most antibiotics used by humans are produced by fungi and certain soil bacteria," he said. "Using our existing tools of discovery, we have failed to uncover any new classes of antibiotics from these sources over the past decade. However, by utilizing a new genetic approach that allowed the team to discover plectasin, we now know that a whole class of antibiotics has been overlooked." "This finding (plectasin), and the existence of about 200,000 additional species of fungi, opens up a vast universe to explore for novel peptide antibiotics," said co-author Robert Lehrer, M.D., Distinguished Professor of Medicine at the David Geffen School of Medicine at UCLA. Plectasin, if proven safe and effective in humans, could be on the market by 2012, said Lehrer. Zasloff and Lehrer are known internationally as experts in antimicrobial peptides - the class of antibiotics that plectasin falls within - and in this study they collaborated with Novozymes, a Danish biotech company that led the research. Zasloff and Lehrer are the only two scientists from U.S. universities on the team of 20 researchers who co-authored the research paper. All life forms have to defend themselves against microbial invaders - bacteria, fungi, viruses - and to do this, they produce antimicrobial defensin peptides. In humans, defensins are made by specific white blood cells and immune cells that later engulf foreign invaders, and by the skin and mucous membranes, in order to kill microbes before they invade protective barriers. Researchers believe that fungi have a similar system of defense, especially since these plant-like organisms live off rotting matter, said Zasloff. "They must compete with other organisms, like bacteria and viruses, which also want to consume the same meal. In addition, they need to defend themselves from being eaten by the microbes which surround them." But he said no one had been able to find defensins in fungi using traditional research techniques, which involved growing fungi in liquid cultures and then testing the culture to see if it contained any antibiotic molecule. The research team instead used the latest genetic science to search for the defensins they thought fungi must have. Selecting the Pseudoplectania nigrella species of fungus may have been serendipitous, Lehrer said, but the Novozymes team used state-of-the-art biotechnology to intercept ,and interpret its genetic messages and exhibited tremendous skill in producing plectasin efficiently, economically, and in large amounts." "I started working on antimicrobial peptides over three decades ago, said Lehrer, and my laboratory first described human defensins in 1985. So, the discovery of plectasin makes me feel like a grandfather." Further examination revealed that this defensin, plectasin, resembles defensins found in spiders, scorpions, dragonflies and mussels - thus suggesting that the defensins found in insects, molluscs and fungi arose from a common ancestral gene, the researchers say. Based on this information, the scientists now believe that defensins appeared in living things more than a billion years ago. The investigators then turned to the National Center for Antimicrobials and Infection Control, the Danish equivalent of the U.S. Centers for Disease Control, to test plectasin in the laboratory for antimicrobial activity against a broad spectrum of bacteria. It showed potent activity against several species of Gram-positive bacteria, and was especially active against S. pneumoniae (the leading cause of pneumonia), including all known clinical strains and those that are now resistant to conventional antibiotics. "That is important because increasing bacterial resistance to conventional antibiotics threatens the future of many antibiotics in current use," Zasloff said. "In mouse studies, plectasin showed extremely low toxicity, and was as effective as vancomycin and penicillin in curing the animals of experimental peritonitis (inflammation of the lining of the abdominal cavity, which can be deadly) and pneumonia caused by S. pneumoniae, the researchers report. "Although the precise mechanism by which plectasin exerts its antimicrobial activity is still under investigation, it may work by a mechanism that is very different from traditional antibiotics, Zasloff said. "As a group, defensins exhibit activity against many types of bacteria, fungi, protozoa, and even viruses. It is entirely possible that fungal defensins will be discovered that could be developed against all of these human pathogens," Zasloff added.

Source: www.news-medical.net ↗
02So, how can this definition challenge be overcome?

To precisely define self and non-self peptides and, in turn, self-similarity, we must first improve our understanding of the adaptive immune cascade and its constituent components. In brief, the fundamental unit of adaptive immune recognition comprises the major histocompatibility complex (MHC) molecules (called the human leukocyte antigen [HLA] in humans), the peptide being presented (and, in turn, identified as self or non-self), and the T cell receptor.

Source: www.news-medical.net ↗
03What Are Rubbing Alcohol and Hydrogen Peroxide?

Both products are antiseptics — germ killers. People started using antiseptics back in the mid-1800s to prevent the spread of bacteria and viruses. Frequent handwashing has reduced the spread of germs in the modern world, but antiseptics are still doing their part. Rubbing alcohol and hydrogen peroxide are two of the most common.

Source: www.webmd.com ↗
04Does theanine interact with foods or drinks?

There are no known interactions between theanine and foods or drinks. But many products that contain theanine also contain caffeine. It may be best to take theanine with a non-caffeinated drink and to limit your total caffeine intake while you are taking theanine. It is unknown if drinking alcohol will affect theanine, but drinking alcohol while taking theanine may increase your risk for sleep problems.

Source: www.webmd.com ↗
05What was this study about?

It has been noted in around 20 percent of the world population suffers from some form of pain or the other. In many individuals, pain may be relieved initially with pain medications, but soon tolerance develops, and there is a decrease in the efficacy of pain relievers. One of the main symptoms of IBS seen commonly in many sufferers is chronic abdominal pain. Professor Lewis said, "All pains are complex, but gut pain is particularly challenging to treat and affects around 20 percent of the world's population. Current drugs are failing to produce effective pain relief in many patients before side effects limit the dose that can be administered." Professor Brierley echoed this statement saying, "Internal organs have a complex network of sensory nerves that have a wide array of voltage-gated ion channels and receptors to detect stimuli... The hypersensitivity of these nerves in disease often contributes to the development of pain."

Source: www.news-medical.net ↗
comparison

Comparisons

Side-by-side pages for commonly compared peptides and research compounds.

Source: peptideuniv.com
Research context

Read sources and limitations before applying a claim.

Evidence-Based, Clinically Guided Care

Sourced from FDA-approved USA manufacturers Our peptide protocols utilize advanced, clinically validated peptides such as CJC-1295, BPC-157, and PT-141. Each treatment plan is grounded in rigorous clinical data and tailored for safe, effective results—helping you optimize your body’s natural repair, recovery, and performance pathways.

Source: extension.health ↗

Longevity, Performance & Obesity Research

A research peptide formulation developed to investigate metabolic regulation, mitochondrial function, and nutrient-sensing pathways.

Source: mypeptidematch.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringe units to draw. This calculator works for single peptide compounds and multi-peptide blends.

Source: peptidemind.com ↗
Side effects

Possible side effects to consider

Is peptide therapy effective for weight loss? Yes, when administered correctly. This treatment produces excellent results with a professionally guided approach. Like most medical procedures, the side effects of peptide therapy are mainly dose-dependent. They may include: Mental side effects. Some peptides only impact the central nervous system. They can affect your cognitive function, causing dizziness, headaches, and fatigue. Allergic reactions. Patients may sometimes experience breathing problems, hives, and swelling, although mild. Gastrointestinal issues. Peptide therapy affecting the digestive system can cause diarrhea, nausea, and vomiting. Cardiovascular problems. Peptides affecting heart operation and blood pressure may cause hypertension, palpitations, and tachycardia. Injection aftermath. Injectable peptides may cause swelling, pain, or reddening on the injection site. Hormonal imbalance. Although rare, peptides affecting hormone levels might cause imbalances. This issue could only arise from incorrect administration. Always seek guidance only from proven specialists. Discuss these potential side effects with your healthcare provider before embarking on treatment. We vouch for the safety of peptide therapy since it mimics what your body produces naturally. Its biological compatibility with the body makes it predictable and rarely risky.

Source: livvnatural.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →